Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ISRCTN76310309) titled 'Comparing intravenous labetalol and nicardipine for controlling severe high blood pressure in pregnant women with severe preeclampsia' on Sept. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Active
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Padjadjaran University
Condition:
Severe preeclampsia requiring acute intravenous antihypertensive treatment.
Pregnancy and Childbirth
Intervention:
Eligible participants were randomly assigned in a 1:1 ratio to receive intravenous labetalol or intravenous nicardipine in two par...